Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 745.29 million compared to CNY 583.05 million a year ago. Revenue was CNY 745.29 million compared to CNY 583.05 million a year ago.

Net income was CNY 188.48 million compared to CNY 97.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.4214 compared to CNY 0.2286 a year ago. Diluted earnings per share from continuing operations was CNY 0.4071 compared to CNY 0.2286 a year ago.